Inventor · disambiguated record
Michael Kormann
Also filed as: KORMANN MICHAEL
3 granted patents·9 pending applications·3 citations·filing 2010–2020
56Inventor score
Files withETHRIS GMBH5UNIV TUEBINGEN MEDIZINISCHE FAKULTAET3UNIV IOWA RES FOUND2EBERHARD KARTS UNIV TUBINGEN MEDIZINISCHE FAKULTAT1RUDOLPH CARSTEN1
Top patents by PatentIndex Score
12 records- 0175US10335498B2RNA based biomaterial for tissue engineering applicationsUNIV IOWA RES FOUND·Filed 2015·Granted Jul 2, 2019·3 cites·18 claims
- 0267US2021095272A1Rna with a combination of unmodified and modified nucleotides for protein expressionETHRIS GMBH·Filed 2020·Application pending·0 cites
- 0360US10745698B2RNA with a combination of unmodified and modified nucleotides for protein expressionETHRIS GMBH·Filed 2015·Granted Aug 18, 2020·0 cites·7 claims
- 0453US11332726B2Permanent gene correction by means of nucleotide-modified messenger RNAUNIV TUEBINGEN MEDIZINISCHE FAKULTAET·Filed 2019·Granted May 17, 2022·0 cites·27 claims
- 0553US2020222559A1Rna based biomaterial for tissue engineering applicationsUNIV IOWA RES FOUND·Filed 2019·Application pending·0 cites
- 0651US2015291678A1Rna with a combination of unmodified and modified nucleotides for protein expressionETHRIS GMBH·Filed 2015·Application pending·0 cites
- 0750US2015290288A1Rna with a combination of unmodified and modified nucleotides for protein expressionETHRIS GMBH·Filed 2015·Application pending·0 cites
- 0850US2015258174A1Rna with a combination of unmodified and modified nucleotides for protein expressionETHRIS GMBH·Filed 2015·Application pending·0 cites
- 0949US2012195936A1Rna with a combination of unmodified and modified nucleotides for protein expressionRUDOLPH CARSTEN·Filed 2010·Application pending·0 cites
- 1046US2020061098A1CHEMICALLY MODIFIED mRNA FOR USE IN THE TREATMENT OF A DISEASE ASSOCIATED WITH THE CFTR GENEUNIV TUEBINGEN MEDIZINISCHE FAKULTAET·Filed 2019·Application pending·0 cites
- 1144US2019040392A1Targeted mrna for in vivo applicationUNIV TUEBINGEN MEDIZINISCHE FAKULTAET·Filed 2018·Application pending·0 cites
- 1239US2016298099A1Permanent gene correction by means of nucleotide-modified messenger rnaEBERHARD KARTS UNIV TUBINGEN MEDIZINISCHE FAKULTAT·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Kormann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →